Asthma Research Today is a free monthly online journal that collates and summarizes the latest research about Asthma, including details on symptoms, diagnosis, treatment, causes, medications.

Volume 2 (2005), Issue 5 (May)

1. Standardised mortality rates in females and males with COPD and asthma.
   Eur Respir J, 25(5): 891-5. [Abstract] [Full-text]
2. Adenosine level in exhaled breath increases during exercise-induced bronchoconstriction.
   Eur Respir J, 25(5): 873-8. [Abstract] [Full-text]
3. Effects of salbutamol and enantiomers on allergen-induced asthmatic reactions and airway hyperreactivity.
   Eur Respir J, 25(5): 864-72. [Abstract] [Full-text]
4. Food allergen sensitization in inner-city children with asthma.
   J Allergy Clin Immunol, 115(5): 1076-80. [Abstract] [Full-text]
5. Relationships among quality of life, severity, and control measures in asthma: an evaluation using factor analysis.
   J Allergy Clin Immunol, 115(5): 1049-55. [Abstract] [Full-text]
6. The asthma and obesity epidemics: the role played by the built environment--a public health perspective.
   J Allergy Clin Immunol, 115(5): 1024-8. [Abstract] [Full-text]
7. Different profiles of T-cell IFN-gamma and IL-12 in allergen-induced early and dual responders with asthma.
   J Allergy Clin Immunol, 115(5): 1004-9. [Abstract] [Full-text]
8. Gradual increase in priming of human eosinophils during extravasation from peripheral blood to the airways in response to allergen challenge.
   J Allergy Clin Immunol, 115(5): 997-1003. [Abstract] [Full-text]
9. Genetic variants of the T-cell immunoglobulin mucin 1 but not the T-cell immunoglobulin mucin 3 gene are associated with asthma in an African American population.
   J Allergy Clin Immunol, 115(5): 982-8. [Abstract] [Full-text]
10. Meta-analysis of the association of beta2-adrenergic receptor polymorphisms with asthma phenotypes.
    J Allergy Clin Immunol, 115(5): 963-72. [Abstract] [Full-text]
11. Allergy and asthma.
    J Allergy Clin Immunol, 115(5): 953-9. [Abstract] [Full-text]
12. Allergen exposure in infancy and the development of sensitization, wheeze, and asthma at 4 years.
    J Allergy Clin Immunol, 115(5): 946-52. [Abstract] [Full-text]
13. Short-term lower-leg growth rate and urine cortisol excretion in children treated with ciclesonide.
    J Allergy Clin Immunol, 115(5): 940-5. [Abstract] [Full-text]
14. Patterns of asthma control: a 3-year analysis of patient claims.
    J Allergy Clin Immunol, 115(5): 935-9. [Abstract] [Full-text]
15. Physical activity and exercise in asthma: relevance to etiology and treatment.
    J Allergy Clin Immunol, 115(5): 928-34. [Abstract] [Full-text]
16. Obesity, smooth muscle, and airway hyperresponsiveness.
    J Allergy Clin Immunol, 115(5): 925-7. [Abstract] [Full-text]
17. The epidemiology of obesity and asthma.
    J Allergy Clin Immunol, 115(5): 897-909; quiz 910. [Abstract] [Full-text]
18. A practitioner-based asthma intervention program with African American inner-city school children.
    J Pediatr Health Care, 19(3): 163-71. [Abstract] [Full-text]
19. Asthma in the pediatric sickle cell patient with acute chest syndrome.
    J Pediatr Health Care, 19(3): 157-62. [Abstract] [Full-text]
20. Impact of a quality improvement program on care and outcomes for children with asthma.
    Arch Pediatr Adolesc Med, 159(5): 464-9. [Abstract] [Full-text]
21. A multisite randomized trial of the effects of physician education and organizational change in chronic asthma care: cost-effectiveness analysis of the Pediatric Asthma Care Patient Outcomes Research Team II (PAC-PORT II).
    Arch Pediatr Adolesc Med, 159(5): 428-34. [Abstract] [Full-text]
22. A randomized trial of primary care provider prompting to enhance preventive asthma therapy.
    Arch Pediatr Adolesc Med, 159(5): 422-7. [Abstract] [Full-text]
23. Racial and ethnic differences in asthma diagnosis among children who wheeze.
    Pediatrics, 115(5): 1254-60. [Abstract] [Full-text]
24. Current asthma and respiratory symptoms among pupils in relation to dietary factors and allergens in the school environment.
    Indoor Air, 15(3): 170-82. [Abstract] [Full-text]
25. Adenoviral gene transfer of the NF-kappa B inhibitory protein ABIN-1 decreases allergic airway inflammation in a murine asthma model.
    J Biol Chem, 280(18): 17938-44. [Abstract] [Full-text]
26. Use of asthma guidelines by primary care providers to reduce hospitalizations and emergency department visits in poor, minority, urban children.
    J Pediatr, 146(5): 591-7. [Abstract] [Full-text]
27. Skin-prick testing as a diagnostic aid for childhood asthma.
    Pediatr Pulmonol, 39(6): 558-62. [Abstract] [Full-text]
28. Is a two-week trial of oral prednisolone predictive of target lung function in pediatric asthma?
    Pediatr Pulmonol, 39(6): 521-7. [Abstract] [Full-text]
29. The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle.
    Am J Respir Crit Care Med, 171(10): 1103-8. [Abstract] [Full-text]
30. Benefit from anti-inflammatory treatment during clinical remission of atopic asthma.
    Respir Med, 99(6): 779-87. [Abstract] [Full-text]
31. Improvement of asthma control with beclomethasone extrafine aerosol compared to fluticasone and budesonide.
    Respir Med, 99(6): 770-8. [Abstract] [Full-text]
32. The relationship between the quality of prescribing and practice appointment rates with asthma management data in those admitted to hospital due to an acute exacerbation.
    Respir Med, 99(6): 735-41. [Abstract] [Full-text]
33. Hypertonicity of the challenge solution may increase the diagnostic accuracy of histamine challenge.
    Respir Med, 99(6): 726-34. [Abstract] [Full-text]
34. Sputum matrix metalloproteases: comparison between chronic obstructive pulmonary disease and asthma.
    Respir Med, 99(6): 703-10. [Abstract] [Full-text]
35. Effects of dual therapy with corticosteroids plus long acting beta2-agonists in asthma.
    Respir Med, 99(6): 683-94. [Abstract] [Full-text]
36. Treating asthma: is there a place for leukotriene receptor antagonists?
    Respir Med, 99(6): 655-62. [Abstract] [Full-text]
37. Immunotherapy: first do no harm.
    Immunol Allergy Clin North Am, 25(2): 421-39, viii. [Abstract] [Full-text]
38. The bronchial lavage of pediatric patients with asthma contains infectious Chlamydia.
    Am J Respir Crit Care Med, 171(10): 1083-8. [Abstract] [Full-text]
39. Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children.
    Am J Respir Crit Care Med, 171(10): 1077-82. [Abstract] [Full-text]
40. Protective effects of tiotropium bromide in the progression of airway smooth muscle remodeling.
    Am J Respir Crit Care Med, 171(10): 1096-102. [Abstract] [Full-text]
41. Effects of allergen inhalation and oral glucocorticoid on concentrations of serum-soluble CD86 in allergic asthmatics.
    Clin Immunol, 115(2): 178-83. [Abstract] [Full-text]
42. Analysis of growth factors and inflammatory cytokines in exhaled breath condensate from asthmatic children.
    Int Arch Allergy Immunol, 137(1): 66-72. [Abstract] [Full-text]
43. Symptoms of asthma and the home environment. The ISAAC I and III cross-sectional surveys in Münster, Germany.
    Int Arch Allergy Immunol, 137(1): 53-61. [Abstract] [Full-text]
44. Elevation of plasma soluble T cell costimulatory molecules CTLA-4, CD28 and CD80 in children with allergic asthma.
    Int Arch Allergy Immunol, 137(1): 45-52. [Abstract] [Full-text]
45. Hypocapnia and asthma: a mechanism for breathing retraining?
    Chest, 127(5): 1808-11. [Abstract] [Full-text]
46. Asthma exacerbations in North American adults: who are the "frequent fliers" in the emergency department?
    Chest, 127(5): 1579-86. [Abstract] [Full-text]
47. Effect of pet removal on pet allergic asthma.
    Chest, 127(5): 1565-71. [Abstract] [Full-text]
48. Leukotriene B4 in exhaled breath condensate and sputum supernatant in patients with COPD and asthma.
    Chest, 127(5): 1553-9. [Abstract] [Full-text]
49. Obtaining optimal control in mild asthma: theory and practice.
    Fam Pract, 22(3): 305-10. [Abstract] [Full-text]
50. The effect of marimastat, a metalloprotease inhibitor, on allergen-induced asthmatic hyper-reactivity.
    Toxicol Appl Pharmacol, 205(2): 126-32. [Abstract] [Full-text]
51. Structural changes in the airways in asthma: observations and consequences.
    Clin Sci (Lond), 108(6): 463-77. [Abstract] [Full-text]
52. Asthma prevalence and severity in Arab American communities in the Detroit area, Michigan.
    J Immigr Health, 7(3): 165-78. [Abstract] [Full-text]
53. Persistence of rhinovirus RNA after asthma exacerbation in children.
    Clin Exp Allergy, 35(5): 672-8. [Abstract] [Full-text]
54. Increase in killer-specific secretory protein of 37 kDa in bronchoalveolar lavage fluid of allergen-challenged patients with atopic asthma.
    Clin Exp Allergy, 35(5): 643-9. [Abstract] [Full-text]
55. Low socioeconomic status as a risk factor for asthma, rhinitis and sensitization at 4 years in a birth cohort.
    Clin Exp Allergy, 35(5): 612-8. [Abstract] [Full-text]
56. Inflammatory cell mapping of the respiratory tract in fatal asthma.
    Clin Exp Allergy, 35(5): 602-11. [Abstract] [Full-text]
57. Bronchoalveolar lavage eosinophil cationic protein and interleukin-8 levels in acute asthma and acute bronchiolitis.
    Clin Exp Allergy, 35(5): 591-7. [Abstract] [Full-text]
58. Association of thromboxane A2 receptor gene polymorphism with the phenotype of acetyl salicylic acid-intolerant asthma.
    Clin Exp Allergy, 35(5): 585-90. [Abstract] [Full-text]
59. Methotrexate therapy of oral corticosteroid-dependent asthmatics reduces serum immunoglobulins: correlation with clinical response to therapy.
    Clin Exp Allergy, 35(5): 579-84. [Abstract] [Full-text]
60. Oligonucleotide-microarray analysis of peripheral-blood lymphocytes in severe asthma.
    J Lab Clin Med, 145(5): 263-74. [Abstract] [Full-text]
61. Supermarket baker's asthma: how accurate is routine health surveillance?
    Occup Environ Med, 62(6): 395-9. [Abstract] [Full-text]
62. Asthma as a risk factor for invasive pneumococcal disease.
    N Engl J Med, 352(20): 2082-90. [Abstract] [Full-text]
63. Evaluation of the potential risk of occupational asthma in dentists exposed to contaminated dental unit waterlines.
    Prim Dent Care, 12(2): 53-9. [Abstract] [Full-text]
64. Functional promoter polymorphism in the TBX21 gene associated with aspirin-induced asthma.
    Hum Genet, 117(1): 16-26. [Abstract] [Full-text]
65. Inhibitors of the tyrosine kinase signaling cascade for asthma.
    Curr Opin Pharmacol, 5(3): 264-71. [Abstract] [Full-text]
66. Matrix metalloproteinases in asthma and COPD.
    Curr Opin Pharmacol, 5(3): 257-63. [Abstract] [Full-text]
67. Targeting the mast cell in asthma.
    Curr Opin Pharmacol, 5(3): 251-6. [Abstract] [Full-text]
68. Life after PDE4: overcoming adverse events with dual-specificity phosphodiesterase inhibitors.
    Curr Opin Pharmacol, 5(3): 238-44. [Abstract] [Full-text]
69. Targeting T cells for asthma.
    Curr Opin Pharmacol, 5(3): 227-31. [Abstract] [Full-text]
70. A pharmacological approach to enhancing the therapeutic index of corticosteroids in airway inflammatory disease.
    Curr Opin Pharmacol, 5(3): 221-6. [Abstract] [Full-text]
71. The Buteyko breathing technique for asthma: a review.
    Complement Ther Med, 13(1): 41-6. [Abstract] [Full-text]
72. Prevalence of asthma by industry in the US population: a study of 2001 NHIS data.
    Am J Ind Med, 47(6): 500-8. [Abstract] [Full-text]
73. Elevated plasma lactate level associated with high dose inhaled albuterol therapy in acute severe asthma.
    Emerg Med J, 22(6): 404-8. [Abstract] [Full-text]
74. Poly(ADP-ribosyl)ation in asthma and other lung diseases.
    Pharmacol Res, 52(1): 83-92. [Abstract] [Full-text]
75. Bronchoprotective and bronchodilator effects of an HFA pMDI vs. a CFC pMDI and a DPI containing formoterol in asthma patients.
    Respiration, 72: 35-7. [Abstract] [Full-text]
76. A randomized, double-blind, double-dummy, safety crossover trial comparing cumulative doses up to 96 microg of formoterol delivered via an HFA-134a-propelled pMDI vs. same cumulative doses of formoterol DPI and placebo in asthmatic patients.
    Respiration, 72: 28-34. [Abstract] [Full-text]
77. Double-blind, double-dummy, multinational, multicenter, parallel-group design clinical trial of clinical non-inferiority of formoterol 12 microg/unit dose in a b.i.d. regimen administered via an HFA-propellant-pMDI or a dry powder inhaler in a 12-week treatment period of moderate to severe stable persistent asthma in adult patients.
    Respiration, 72: 20-7. [Abstract] [Full-text]
78. A randomized, double-blind, double-dummy, single-dose, crossover trial evaluating the efficacy and safety profiles of two dose levels (12 and 24 microg) of formoterol-HFA (pMDI) vs. those of a dose level (24 microg) of formoterol-DPI (Foradil/Aerolizer) and of placebo (pMDI or Aerolizer) in moderate to severe asthmatic patients.
    Respiration, 72: 13-9. [Abstract] [Full-text]
79. A randomized, double-blind, double-dummy, single-dose, efficacy crossover trial comparing formoterol-HFA (pMDI) versus formoterol-DPI (Aerolizer) and placebo (pMDI or Aerolizer) in asthmatic patients.
    Respiration, 72: 6-12. [Abstract] [Full-text]
80. Asthma: one hundred years of treatment and onward.
    Am J Respir Crit Care Med, 171(11): 1202-8. [Abstract] [Full-text]
81. Comparison of inhaled fluticasone with intravenous hydrocortisone in the treatment of adult acute asthma.
    Am J Respir Crit Care Med, 171(11): 1231-6. [Abstract] [Full-text]
82. Asthma and panic in young adults: a 20-year prospective community study.
    Am J Respir Crit Care Med, 171(11): 1224-30. [Abstract] [Full-text]
83. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma.
    N Engl J Med, 352(21): 2163-73. [Abstract] [Full-text]
84. Impact of exogenous glucocorticoid use on salivary cortisol measurements among adults with asthma and rhinitis.
    Psychoneuroendocrinology, 30(8): 744-52. [Abstract] [Full-text]
85. Traffic related air pollution as a determinant of asthma among Taiwanese school children.
    Thorax, 60(6): 467-73. [Abstract] [Full-text]
86. C reactive protein levels are increased in non-allergic but not allergic asthma: a multicentre epidemiological study.
    Thorax, 60(6): 451-4. [Abstract] [Full-text]
87. Association of asthma and hay fever with irregular menstruation.
    Thorax, 60(6): 445-50. [Abstract] [Full-text]
88. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
    Clin Ther, 27(4): 393-406. [Abstract] [Full-text]
89. Short-term and long-term asthma control in patients with mild persistent asthma receiving montelukast or fluticasone: a randomized controlled trial.
    Am J Med, 118(6): 649-57. [Abstract] [Full-text]
90. Is mild asthma really 'mild'?
    Int J Clin Pract, 59(6): 692-703. [Abstract] [Full-text]

© 2004-2008 Asthma Research Today. All Rights Reserved.